Study of Effects of L-Arginine in Colitis and Colon Cancer

Completed

Conditions studied: Ulcerative Colitis, Colon Cancer

In brief

The purpose of this study is to look at the importance of L-Arginine in the digestive tract. L-Arginine is an amino acid and is important in making proteins within the cell. The evaluation of colon tissue, blood, urine, diet, health history, and symptoms will help us learn more about L-Arginine and ulcerative colitis. The investigators believe these studies will provide new insights into the treatment for Inflammatory Bowel Disease (ulcerative colitis) and nutritional needs. The investigators plan to enroll 200 participants in this study over the next two years.

Key facts

Study ID

NCT01091558

Run by

Vanderbilt University Medical Center

People needed

204

Starts

2009-09-01

Expected to finish

2011-12-01

Last updated by the study team

2017-03-31

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 years of age or older
• Colonoscopy for one of the following: clinical indications, disease assessment, or surveillance for dysplasia (as in ulcerative colitis)
• Screening for cancer

You may not qualify if…

• refusal to participate
• age less than 18 years at time of colonoscopy

Where it is running

• Vanderbilt Hospital — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.